IRIS
BERTINO, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.489
EU - Europa 5.572
AS - Asia 5.397
SA - Sud America 1.113
AF - Africa 763
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 11
Totale 23.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.100
SG - Singapore 2.807
RU - Federazione Russa 1.715
CN - Cina 1.380
IT - Italia 1.141
BR - Brasile 927
IE - Irlanda 874
UA - Ucraina 796
VN - Vietnam 459
CI - Costa d'Avorio 405
CA - Canada 313
FR - Francia 295
KR - Corea 179
NG - Nigeria 157
GB - Regno Unito 148
DE - Germania 139
SE - Svezia 122
IN - India 118
SN - Senegal 80
BD - Bangladesh 73
AR - Argentina 59
HK - Hong Kong 56
MX - Messico 50
PL - Polonia 50
NL - Olanda 49
FI - Finlandia 48
TR - Turchia 48
IQ - Iraq 47
ZA - Sudafrica 39
ES - Italia 31
UZ - Uzbekistan 30
JP - Giappone 29
AT - Austria 28
EC - Ecuador 27
BE - Belgio 26
CO - Colombia 26
CZ - Repubblica Ceca 23
ID - Indonesia 21
MA - Marocco 21
PK - Pakistan 21
VE - Venezuela 20
CH - Svizzera 19
KE - Kenya 18
SA - Arabia Saudita 16
GR - Grecia 15
CL - Cile 14
IR - Iran 14
NP - Nepal 14
PY - Paraguay 13
PE - Perù 12
JO - Giordania 11
PH - Filippine 11
AU - Australia 10
EU - Europa 10
IL - Israele 9
QA - Qatar 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
BJ - Benin 8
LT - Lituania 8
MY - Malesia 8
TN - Tunisia 8
BG - Bulgaria 7
JM - Giamaica 7
ET - Etiopia 6
KZ - Kazakistan 6
LB - Libano 6
RO - Romania 6
AO - Angola 5
DZ - Algeria 5
PA - Panama 5
RS - Serbia 5
EG - Egitto 4
HR - Croazia 4
AL - Albania 3
BO - Bolivia 3
GA - Gabon 3
HN - Honduras 3
HU - Ungheria 3
PS - Palestinian Territory 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
SR - Suriname 2
BB - Barbados 1
BN - Brunei Darussalam 1
DK - Danimarca 1
GH - Ghana 1
GI - Gibilterra 1
GP - Guadalupe 1
Totale 23.342
Salva come PNG Salva come JPEG
Città #
Dallas 2.045
Singapore 1.641
Santa Clara 1.139
Dublin 869
Chandler 747
Moscow 701
Jacksonville 692
San Jose 680
Ashburn 440
Abidjan 405
Chicago 404
Boardman 349
Los Angeles 279
Nanjing 248
Lawrence 241
Andover 239
Cambridge 238
Lauterbourg 229
Toronto 225
Beijing 200
Catania 197
Seoul 179
Hefei 173
Houston 149
Ho Chi Minh City 144
Des Moines 126
Council Bluffs 122
Hanoi 108
Wilmington 99
San Mateo 98
Civitanova Marche 97
New York 88
Abuja 86
São Paulo 85
Dakar 80
Shenyang 75
Buffalo 69
Nanchang 69
Saint Petersburg 65
Milan 59
Hebei 54
Lagos 54
Changsha 51
Palermo 49
Hong Kong 46
Ottawa 46
Bremen 45
The Dalles 45
Tianjin 44
Jiaxing 42
Rome 42
Mountain View 41
Columbus 38
Brooklyn 37
Warsaw 37
Orem 33
Dong Ket 29
Belo Horizonte 28
Munich 27
Brussels 26
Kochi 26
Mascalucia 26
Tokyo 26
Montreal 25
Chennai 24
Johannesburg 24
London 24
Rio de Janeiro 24
Baghdad 22
Da Nang 22
Amsterdam 21
Mumbai 21
Turku 21
Atlanta 20
Denver 19
Manchester 19
Stockholm 19
Haiphong 18
Boston 17
Frankfurt am Main 17
Port Harcourt 17
Dhaka 16
Naples 16
Norwalk 16
Phoenix 16
Brasília 15
Falls Church 15
Gravina di Catania 15
Redondo Beach 15
San Francisco 15
Lappeenranta 14
Redmond 14
Seattle 14
Tashkent 14
Washington 14
Guangzhou 13
Mexico City 13
Paris 13
Porto Alegre 13
Pune 13
Totale 15.719
Salva come PNG Salva come JPEG
Nome #
Malattie dell'apparato digerente. Edizione 2025-2028 273
A study about mechanism of des-gamma-carboxy prothrombin’s production in hepatocellular carcinoma 221
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 219
Carbohydrate 19.9 Antigen Serum Levels in Liver Disease 213
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 209
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 204
Anorectal mucosal melanoma 194
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 190
Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer 187
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 182
Assessing degree of hepatic fibrosis in patients with chronic liver disease using gadoxetic acid-enhanced liver MRI: Preliminary results 179
Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study 172
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives 169
Commentary on "Insertion of Totally Implantable Central Venous Access Devices by Surgeons" - What Is the Role of Surgeons When Implanting a Totally Implantable Venous Access Device to Prevent Immediate Complications? 164
D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis 164
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 163
High carbohydrate 19-9 antigen serum levels in patients with nonmelanoma skin cancer and primary occult cancer 163
Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Non-Alcoholic Fatty Liver Disease 160
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance 157
Acetyl-L-carnitine can slow the progression from prefrailty to frailty in older subjects. A randomized interventional clinical trial 154
Evaluation of health status in patients with hepatitis c treated with and without interferon 154
Homocysteine serum levels as prognostic marker of hepatocellular carcinoma with portal vein thrombosis 154
Folate levels in hepatocellular carcinoma patients with portal vein thrombosis 153
Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis 152
Hepatocellular carcinoma serum markers 151
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine 150
A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. 145
An unusual case of HBV reactivation in a patient with cholangitis and choledocho-lithiasis undergone to ERCP. A case report 145
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature 142
Obesity and related diseases: an epidemiologic study in Eastern Sicily 141
Eterozigosi H36D per Emocromatosi in pazienti affetti da Steatoepatite e Epatite cronica da virus C 140
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study 139
Association Between Diabetes Mellitus, Hepatic Steatosis And Fibrosis In Chronic Hepatitis C Patients 139
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin 139
A therapeutic education and medical support program improves adherence to therapy with peg-interferon plus ribavirin therapy and increases sustained virological response in patients with chronic hepatitis C 138
A phase IIIb, 2X2 factorial, double blind study of 48 versus 96 weeks of peg-Interferon alpha 2a 180 micrg, with or without 24 weeks of Entecavir in adult patients with HbeAg negative chronic hepatitis B 136
Circulating adhesion molecules in patients with virus-related chronic diseases of the liver 133
Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis 132
A case of Overlap Syndrome:Autoimmune idiopatic hepatitis/pulmonary idiopatic hypertension 132
Carbohydrate 19-9 antigen in chronic viral hepatitis without neoplasia is associated with the severity of liver disease 130
Carnitine Serum Levels in Frail Older Subjects 129
Rare benign tumors of the liver: still rare? 127
Biochemical long-term outcomes in chronic hepatitis C patients treated with a twelve months course of alpha lymphoblastoid interferon 126
Type II Mixed Cryoglobulinemia In Patients With Hepatitis C Virus: Treatment with Pegylated-Interferon and Ribavirin 126
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic epatiti C treated with pegylated interferon α and ribavirin 126
Resveratrol in Patients with Minimal Hepatic Encephalopathy 126
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 124
Laparoscopic Reversal of Hartmann's Procedure: State of the Art 20 Years after the First Reported Case 123
Digestive diseases. 2022-2025 edition 122
Possibile associazione di anemia normocromica con maggiore incremento delle molecole di adesione ICAM-2 e VCAM-1 in pazienti con cirrosi epatica: studio pilota 122
Systemic Therapies in Hepatocellular carcinoma: present and future 122
Eritropoietina nel trattamento dell'anemia secondaria a terapia con interferone peghilato e ribavirina 121
Hepatocellular carcinoma and the risk of occupational exposure. 120
Behavior of alpha-1-antitrypsin in adults with chronic liver disease 119
Circulating erytropoietin in microalbuminuric type 2 diabetic patients with normal renal function: a pilot study 118
ON-TREATMENT SERUM HBsAG DECLINE DURING TELBIVUDINE THERAPY IN NAÏVE CHRONIC HEPATITIS B: CASE REPORT 118
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 118
AIDS. Sindrome da Immunodeficienza Acquisita 117
Giant cavernous liver hemangiomas: is it the time to change the size categories? 117
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study 117
Genotype-phenotype variable correlation in Wilson disease: clinical history of two sisters with the similar genotype 117
Hepatocellular Carcinoma 116
Obesity as a Confounding Factor in the Diagnosis of Wilson’s Disease: Case Report of Two Siblings with the Same Genotype but Different Clinical Courses 113
Telbivudine on-treatment HBsAg loss in naïve HBeAg negative chronic hepatitis B: A case report and brief review of the literature 113
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 112
Silybin supplementation during HCV therapy with pegylated interferon-a plus ribavirin reduces depression and anxiety and increases work ability 112
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 111
Rosuvastatin reduces non alcoholic fatty liver diseasa in patients with chronic hepatitis C treated with alpha-interferon and ribavirin 110
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study 109
Trattamento con peg-interferone e ribavirina nell’epatite cronica attiva C ed insorgenza di malattia celiaca: esiste una relazione ? 108
Does follow-up offer the best quality of life for patients affected by so-called 'giant' haemangiomas of the liver? 108
Chronic anaemia and adhesion molecules in patients with liver cirrhosis. A preliminary report 107
Eritropoietina nel trattamento dell’anemia secondaria a terapia con interferone peghilato e ribavirina 107
Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment 104
Epatite cronica: un caso di sovrapposizione epatite autoimmune-epatite virale 104
Hepatocellular carcinoma markers in the omics era: the glycomic analysis 101
REAL-WORLD DATA ON LONG TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID FOR PRIMARY BILIARY CHOLANGITIS: FIRST RELEASE FROM THE ITALIAN RECAPITULATE STUDY 100
Incidence and causes of neonatal hyperbilirubinemia in a center of Catania 100
ON-TREATMENT HBsAg DECLINE IS ASSOCIATED WITH SUBSEQUENT HBsAg REDUCTION IN HBeAg NEGATIVE CHRONIC HEPATITIS B 100
Riduzione della densità minerale ossea volumetrica (pQCT) in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 100
Priority of the chronic HBV pathology in a samples of subjects suffering from liver disorder and hospitalized in the last triennium 99
Co-administration ezetimibe/simvastatin teraphy decrease the supersaturation in gallbladder bile and prevent cholesterol gallstones formation 99
Vaccinazione anti-epatite B: differenze della risposta immune con Hevac B Pasteur in rapporto all'età 99
Combined duodenal and pancreatic major trauma in high risk patients: can a partial reconstruction be safe? 99
Ferro e ferrodeplezione nell'epatite cronica HCV-correlata 98
Trattamento dell'epatite cronica B, HBeAg negativa, con terapia di combinazione: Adefovir e Interferone-Pegilato alfa 2a vs Adefovir (Studio PAC: Peg Adefovir Combination) 98
Totally Implantable Venous Access Devices: Efforts Are Needed to Standardize Procedures to Avoid Complications 98
Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments 98
Endozepine-4 levels are increased in hepatic coma. 96
POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 95
Ferro e ferrodeplezione nell'epatite cronica HCV-correlata.Studio pilota 94
Current practice of chronic hepatitis B treatment in Southern Italy 94
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 93
What are the true advantages of devices for hepatic parenchimal transection in open surgery? 93
CO-ADMINISTRATION EZETIMIBE/SIMVASTATIN TERAPHY DECREASES THE SUPER-SATURATION IN GALLBLADDER BILE AND PREVENT CHOLESTEROL GALLSTONES FORMATION 92
Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study 92
INFEZIONE DA HAV IN PAZIENTI CON EPATITE CRONICA HCV-CORRELATA 92
Hepatocellular Carcinoma: present and future 92
Delta infection in eastern Sicily 91
La metalloproteinasi-2 è un marker indiretto di citonecrosi e fibrosi epatica nell’epatite cronica HCV-correlata 91
Totale 13.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.482
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021322 0 0 0 0 0 0 0 0 0 60 183 79
2021/20221.735 222 279 20 27 267 14 255 55 137 6 62 391
2022/20232.609 257 97 40 229 241 442 17 449 673 25 79 60
2023/20241.222 69 162 45 56 49 264 24 91 13 41 230 178
2024/20254.856 77 754 306 226 1.002 549 150 190 343 539 346 374
2025/202610.114 611 556 2.235 619 1.561 1.900 1.228 287 585 532 0 0
Totale 23.965